AiPing Pharmaceutical Inc RX
FDA Approved Drugs

AiPing Pharmaceutical Inc RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 86
  • Latest Approval Date Jun 24, 2026
  • Data Source FDA
  • First Approval Date Feb 17, 1987
All
141
View
Discontinued
55
View
RX
86
View
Company Overview

Company

AiPing Pharmaceutical Inc RX

Country

U.S.A

Website

Visit Website

Email

solutions@aipingpharma.com

Social Profiles

Company Snapshot

AiPing Pharmaceutical Inc RX

350 W Wireless Boulevard\nHauppauge, NY

U.S.A

www.aipingpharmaceutical.com/ solutions@aipingpharma.com View on Map
FDA Approved Drug Records ( 86 records )
2020
07 Apr
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-07

212654 / 1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2020-04-07

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-29

212654 / 2

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2021-09-29

212654 / 3

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2021-09-29

212654 / 4

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2021-09-29

212654 / 5

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

5

Dosage Form

-

Strength

100MG

Approval Date

2021-09-29

Regulatory Status

RX

2021
29 Sep
RX Application: 212654

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Product Number

6

Dosage Form

-

Strength

150MG

Approval Date

2021-09-29

212654 / 6

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

6

Dosage Form

-

Strength

150MG

Approval Date

2021-09-29

Regulatory Status

RX

2024
02 Apr
RX Application: 214901

Drug Name

ARFORMOTEROL TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2024-04-02

214901 / 1

Active Ingredient

ARFORMOTEROL TARTRATE

Application Number

214901

Product Number

1

Dosage Form

-

Strength

EQ 0.015MG BASE/2ML

Approval Date

2024-04-02

Regulatory Status

RX

1988
15 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1988-07-15

72304 / 1

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1988-07-15

Regulatory Status

RX

1992
31 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1992-07-31

72304 / 2

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

1992-07-31

Regulatory Status

RX

1988
18 Jul
RX Application: 72304

Drug Name

ATENOLOL

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1988-07-18

72304 / 3

Active Ingredient

ATENOLOL

Application Number

72304

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

1988-07-18

Regulatory Status

RX

1990
31 May
RX Application: 72302

Drug Name

ATENOLOL AND CHLORTHALIDONE

Product Number

1

Dosage Form

-

Strength

100MG;25MG

Approval Date

1990-05-31

72302 / 1

Active Ingredient

ATENOLOL; CHLORTHALIDONE

Application Number

72302

Product Number

1

Dosage Form

-

Strength

100MG;25MG

Approval Date

1990-05-31

Regulatory Status

RX

1990
31 May
RX Application: 72302

Drug Name

ATENOLOL AND CHLORTHALIDONE

Product Number

2

Dosage Form

-

Strength

50MG;25MG

Approval Date

1990-05-31

72302 / 2

Active Ingredient

ATENOLOL; CHLORTHALIDONE

Application Number

72302

Product Number

2

Dosage Form

-

Strength

50MG;25MG

Approval Date

1990-05-31

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1996-12-12

40103 / 1

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

1

Dosage Form

-

Strength

0.5MG

Approval Date

1996-12-12

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

1996-12-12

40103 / 2

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

2

Dosage Form

-

Strength

1MG

Approval Date

1996-12-12

Regulatory Status

RX

1996
12 Dec
RX Application: 40103

Drug Name

BENZTROPINE MESYLATE

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

1996-12-12

40103 / 3

Active Ingredient

BENZTROPINE MESYLATE

Application Number

40103

Product Number

3

Dosage Form

-

Strength

2MG

Approval Date

1996-12-12

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-12-16

202087 / 1

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-12-16

202087 / 2

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2015-12-16

202087 / 3

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

3

Dosage Form

-

Strength

15MG

Approval Date

2015-12-16

Regulatory Status

RX

2015
16 Dec
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

30MG

Approval Date

2015-12-16

202087 / 4

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

4

Dosage Form

-

Strength

30MG

Approval Date

2015-12-16

Regulatory Status

RX

2025
03 Jul
RX Application: 202087

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

7.5MG

Approval Date

2025-07-03

202087 / 5

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

202087

Product Number

5

Dosage Form

-

Strength

7.5MG

Approval Date

2025-07-03

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2023-01-27

214442 / 1

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-01-27

214442 / 2

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2023-01-27

214442 / 3

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

2023-01-27

Regulatory Status

RX

2023
27 Jan
RX Application: 214442

Drug Name

CAPTOPRIL

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-01-27

214442 / 4

Active Ingredient

CAPTOPRIL

Application Number

214442

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

2023-01-27

Regulatory Status

RX

2022
21 Jan
RX Application: 214877

Drug Name

CHOLESTYRAMINE

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

2022-01-21

214877 / 1

Active Ingredient

CHOLESTYRAMINE

Application Number

214877

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

2022-01-21

Regulatory Status

RX

2022
21 Jan
RX Application: 214877

Drug Name

CHOLESTYRAMINE

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

2022-01-21

214877 / 2

Active Ingredient

CHOLESTYRAMINE

Application Number

214877

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

2022-01-21

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-06-09

76593 / 2

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

2

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2004-06-09

76593 / 3

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

2004
09 Jun
RX Application: 76593

Drug Name

CIPROFLOXACIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2004-06-09

76593 / 4

Active Ingredient

CIPROFLOXACIN HYDROCHLORIDE

Application Number

76593

Product Number

4

Dosage Form

-

Strength

EQ 750MG BASE

Approval Date

2004-06-09

Regulatory Status

RX

2026
13 May
RX Application: 72854

Drug Name

CYCLOBENZAPRINE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-13

72854 / 3

Active Ingredient

CYCLOBENZAPRINE HYDROCHLORIDE

Application Number

72854

Product Number

3

Dosage Form

-

Strength

7.5MG

Approval Date

2026-05-13

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2020-07-28

213474 / 1

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2020-07-28

213474 / 2

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

2

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-07-28

213474 / 3

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

3

Dosage Form

-

Strength

EQ 50MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2020-07-28

213474 / 4

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

4

Dosage Form

-

Strength

EQ 75MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2020
28 Jul
RX Application: 213474

Drug Name

DOXEPIN HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-07-28

213474 / 5

Active Ingredient

DOXEPIN HYDROCHLORIDE

Application Number

213474

Product Number

5

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2020-07-28

Regulatory Status

RX

2025
01 Oct
RX Application: 219978

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2025-10-01

219978 / 1

Active Ingredient

DOXYCYCLINE

Application Number

219978

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

2025-10-01

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-03-23

75178 / 1

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2001-03-23

75178 / 2

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2001-03-23

75178 / 3

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2001-03-23

Regulatory Status

RX

2001
23 Mar
RX Application: 75178

Drug Name

ENALAPRIL MALEATE

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2001-03-23

75178 / 4

Active Ingredient

ENALAPRIL MALEATE

Application Number

75178

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

2001-03-23

Regulatory Status

RX

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2000-11-29

75888 / 1

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2000-11-29

Regulatory Status

RX

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2000-11-29

75888 / 2

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2000-11-29

Regulatory Status

RX

2000
29 Nov
RX Application: 75888

Drug Name

FLUVOXAMINE MALEATE

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2000-11-29

75888 / 3

Active Ingredient

FLUVOXAMINE MALEATE

Application Number

75888

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2000-11-29

Regulatory Status

RX

2013
12 Jul
RX Application: 91145

Drug Name

FOLIC ACID

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-07-12

91145 / 1

Active Ingredient

FOLIC ACID

Application Number

91145

Product Number

1

Dosage Form

-

Strength

1MG

Approval Date

2013-07-12

Regulatory Status

RX

1995
07 Apr
RX Application: 74305

Drug Name

GLIPIZIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1995-04-07

74305 / 1

Active Ingredient

GLIPIZIDE

Application Number

74305

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1995-04-07

Regulatory Status

RX

1995
07 Apr
RX Application: 74305

Drug Name

GLIPIZIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

1995-04-07

74305 / 2

Active Ingredient

GLIPIZIDE

Application Number

74305

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

1995-04-07

Regulatory Status

RX

2022
08 Jun
RX Application: 216399

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2022-06-08

216399 / 1

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216399

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2022-06-08

Regulatory Status

RX

2022
08 Jun
RX Application: 216399

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2022-06-08

216399 / 2

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216399

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2022-06-08

Regulatory Status

RX

1987
17 Feb
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

1987-02-17

71130 / 1

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

1987-02-17

Regulatory Status

RX

1987
17 Feb
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1987-02-17

71130 / 2

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

1987-02-17

Regulatory Status

RX

1987
12 May
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

1987-05-12

71130 / 3

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

1987-05-12

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

4

Dosage Form

-

Strength

0.5MG

Approval Date

2026-04-08

71130 / 4

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

4

Dosage Form

-

Strength

0.5MG

Approval Date

2026-04-08

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-08

71130 / 5

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

5

Dosage Form

-

Strength

1MG

Approval Date

2026-04-08

Regulatory Status

RX

2026
08 Apr
RX Application: 71130

Drug Name

HALOPERIDOL

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2026-04-08

71130 / 6

Active Ingredient

HALOPERIDOL

Application Number

71130

Product Number

6

Dosage Form

-

Strength

20MG

Approval Date

2026-04-08

Regulatory Status

RX

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1998-08-04

75113 / 1

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1998-08-04

Regulatory Status

RX

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

1998-08-04

75113 / 2

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

1998-08-04

Regulatory Status

RX

1998
04 Aug
RX Application: 75113

Drug Name

LABETALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

1998-08-04

75113 / 3

Active Ingredient

LABETALOL HYDROCHLORIDE

Application Number

75113

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

1998-08-04

Regulatory Status

RX

2016
26 Aug
RX Application: 204754

Drug Name

LEVETIRACETAM

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-08-26

204754 / 1

Active Ingredient

LEVETIRACETAM

Application Number

204754

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

2016-08-26

Regulatory Status

RX

2016
26 Aug
RX Application: 204754

Drug Name

LEVETIRACETAM

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-08-26

204754 / 2

Active Ingredient

LEVETIRACETAM

Application Number

204754

Product Number

2

Dosage Form

-

Strength

750MG

Approval Date

2016-08-26

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

1

Dosage Form

-

Strength

12.5MG;10MG

Approval Date

2002-07-01

76262 / 1

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

1

Dosage Form

-

Strength

12.5MG;10MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

2

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2002-07-01

76262 / 2

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

2

Dosage Form

-

Strength

12.5MG;20MG

Approval Date

2002-07-01

Regulatory Status

RX

2002
01 Jul
RX Application: 76262

Drug Name

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Number

3

Dosage Form

-

Strength

25MG;20MG

Approval Date

2002-07-01

76262 / 3

Active Ingredient

HYDROCHLOROTHIAZIDE; LISINOPRIL

Application Number

76262

Product Number

3

Dosage Form

-

Strength

25MG;20MG

Approval Date

2002-07-01

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

90544 / 1

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

2010-10-06

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

90544 / 2

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

2010-10-06

Regulatory Status

RX

2010
06 Oct
RX Application: 90544

Drug Name

LOSARTAN POTASSIUM

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

90544 / 3

Active Ingredient

LOSARTAN POTASSIUM

Application Number

90544

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

2010-10-06

Regulatory Status

RX

2006
19 Jul
RX Application: 77920

Drug Name

MELOXICAM

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2006-07-19

77920 / 1

Active Ingredient

MELOXICAM

Application Number

77920

Product Number

1

Dosage Form

-

Strength

7.5MG

Approval Date

2006-07-19

Regulatory Status

RX

2006
19 Jul
RX Application: 77920

Drug Name

MELOXICAM

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2006-07-19

77920 / 2

Active Ingredient

MELOXICAM

Application Number

77920

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2006-07-19

Regulatory Status

RX

2005
18 Feb
RX Application: 40547

Drug Name

METHIMAZOLE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-02-18

40547 / 1

Active Ingredient

METHIMAZOLE

Application Number

40547

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2005-02-18

Regulatory Status

RX

2005
18 Feb
RX Application: 40547

Drug Name

METHIMAZOLE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-02-18

40547 / 2

Active Ingredient

METHIMAZOLE

Application Number

40547

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

2005-02-18

Regulatory Status

RX

1990
30 Jan
RX Application: 72215

Drug Name

METOCLOPRAMIDE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1990-01-30

72215 / 1

Active Ingredient

METOCLOPRAMIDE HYDROCHLORIDE

Application Number

72215

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

1990-01-30

Regulatory Status

RX

2024
05 Nov
RX Application: 72215

Drug Name

METOCLOPRAMIDE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2024-11-05

72215 / 2

Active Ingredient

METOCLOPRAMIDE HYDROCHLORIDE

Application Number

72215

Product Number

2

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2024-11-05

Regulatory Status

RX

1996
31 Jul
RX Application: 74625

Drug Name

OXYBUTYNIN CHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1996-07-31

74625 / 1

Active Ingredient

OXYBUTYNIN CHLORIDE

Application Number

74625

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1996-07-31

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

78670 / 1

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

1

Dosage Form

-

Strength

EQ 15MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

78670 / 2

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

2013
13 Feb
RX Application: 78670

Drug Name

PIOGLITAZONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

78670 / 3

Active Ingredient

PIOGLITAZONE HYDROCHLORIDE

Application Number

78670

Product Number

3

Dosage Form

-

Strength

EQ 45MG BASE

Approval Date

2013-02-13

Regulatory Status

RX

2025
28 Jan
RX Application: 217857

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

330MG

Approval Date

2025-01-28

217857 / 1

Active Ingredient

PREGABALIN

Application Number

217857

Product Number

1

Dosage Form

-

Strength

330MG

Approval Date

2025-01-28

Regulatory Status

RX

2026
24 Jun
RX Application: 217857

Drug Name

PREGABALIN

Product Number

2

Dosage Form

-

Strength

165MG

Approval Date

2026-06-24

217857 / 2

Active Ingredient

PREGABALIN

Application Number

217857

Product Number

2

Dosage Form

-

Strength

165MG

Approval Date

2026-06-24

Regulatory Status

RX

1996
22 Feb
RX Application: 73263

Drug Name

PREVALITE

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

1996-02-22

73263 / 1

Active Ingredient

CHOLESTYRAMINE

Application Number

73263

Product Number

1

Dosage Form

-

Strength

EQ 4GM RESIN/PACKET

Approval Date

1996-02-22

Regulatory Status

RX

1997
30 Oct
RX Application: 73263

Drug Name

PREVALITE

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

1997-10-30

73263 / 2

Active Ingredient

CHOLESTYRAMINE

Application Number

73263

Product Number

2

Dosage Form

-

Strength

EQ 4GM RESIN/SCOOPFUL

Approval Date

1997-10-30

Regulatory Status

RX

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

216995 / 1

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

216995 / 2

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

2

Dosage Form

-

Strength

15MG

Approval Date

2025-05-14

Regulatory Status

RX

2025
14 May
RX Application: 216995

Drug Name

RIVAROXABAN

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

216995 / 3

Active Ingredient

RIVAROXABAN

Application Number

216995

Product Number

3

Dosage Form

-

Strength

20MG

Approval Date

2025-05-14

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2001-04-27

75500 / 1

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2001-04-27

75500 / 2

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

2

Dosage Form

-

Strength

160MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

3

Dosage Form

-

Strength

240MG

Approval Date

2001-04-27

75500 / 3

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

3

Dosage Form

-

Strength

240MG

Approval Date

2001-04-27

Regulatory Status

RX

2001
27 Apr
RX Application: 75500

Drug Name

SORINE

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

2001-04-27

75500 / 4

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75500

Product Number

4

Dosage Form

-

Strength

120MG

Approval Date

2001-04-27

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    141 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
86 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMITRIPTYLINE HYDROCHLORIDE

Application Number

212654

Product Number

1

Active Ingredient

AMITRIPTYLINE HYDROCHLORIDE

Dosage Form

-

Strength

25MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit